Evidence map›Paper›PMID 27766259›Full record

ArticleBioMed research international2016

High Efficient Expression, Purification, and Functional Characterization of Native Human Epidermal Growth Factor in

Yi Ma, Jieying Yu, Jinglian Lin, Shaomin Wu, Shan Li, Jufang Wang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Activity and Effectiveness of Recombinant hEGF Excreted byJournal of experimental pharmacology · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yi MaSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Jieying YuSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Jinglian LinSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Shaomin WuSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Shan LiSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China; Guangdong Province Key Laboratory of Fermentation and Enzyme Engineering, South China University of Technology, Guangzhou 510006, China.ORCID 0000-0002-5211-0872
Jufang WangSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.ORCID 0000-0002-9908-1001
South China University of Technology · CN

Funding

NICHD NIH HHS N01 AA021004
6 · The paper itself

Abstract

Human epidermal growth factor (hEGF) is a small, mitotic growth polypeptide that promotes the proliferation of various cells and is widely applied in clinical practices. However, high efficient expression of native hEGF in

Indexed as

3T3 CellsAnimalsCell ProliferationCloning, MolecularDNA GyraseEpidermal Growth FactorEscherichia coliGenetic EnhancementHistidineHumansMiceProtein EngineeringRecombinant ProteinsSUMO-1 ProteinDNA GyraseEpidermal Growth FactorHistidineRecombinant ProteinsSUMO-1 Protein

Identifiers

PMID27766259
PMCPMC5059520
OpenAlexW2524393404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.